[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/pages/docs/Benef/index.md) >> Individual ID:PBN__Benef_632 

# __Reduced financial losses__

## Articles mentionning this Benefit

* [The efficacy of social distance and ventilation effectiveness in preventing COVID-19 transmission](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_125.md)

## Category to which it belongs

* [Improved financial outcomes through financial relief, increased funding, sustainable and additional funding, private investment, and reduced financial losses.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_20.md)

## Description of actual returns pertaining to this benefit

* [Private investors investing in social distancing measures would benefit from reduced financial losses and business disruptions associated with covid-19 outbreaks.](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_680.md)

## Name of the Benefit

Social distancing measures can help prevent outbreaks of COVID-19 in workplaces and public spaces, reducing the risk of closures, loss of revenue, and legal liabilities.

## Risks which can benefit from this action

* [Social distancing](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_275.md)

## Stakeholders benefitting from this Benefit

* [Businesses and organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_262.md)

## This benefit is realized in the following general blueprint(s)

* [Implementing Disease Control Strategies: Mitigating Contagion Risks through Hygiene Measures and Rapid Isolation](https://github.com/mm80843/T3.5/blob/pages/aBlueprint/PBN__aBlueprint_2.md)
* [Implementing Effective Measures to Combat Contagious Diseases](https://github.com/mm80843/T3.5/blob/pages/aBlueprint/PBN__aBlueprint_33.md)
* [Implementing Strategic Measures to Counteract Contagious Diseases](https://github.com/mm80843/T3.5/blob/pages/aBlueprint/PBN__aBlueprint_41.md)

